LONDON (Alliance News) - Gains for Next and Royal Bank of Scotland early Thursday saw the FTSE 100 climb to its best level since late January, though the blue-chip a Read More
LONDON (Alliance News) - FTSE 100-listed drugmaker GlaxoSmithKline PLC said Wednesday that Chief Financial Officer Simon Dingemans will retire from the company in May 2019.The company will Read More
LONDON (Alliance News) - Drugmaker GlaxoSmithKline PLC on Wednesday reported a drop in first-quarter earnings and warned of the negative impact of currency movements on the remainder the year, on Read More
LONDON (Alliance News) - Drugmaker GlaxoSmithKline PLC on Wednesday reported a drop in first quarter earnings and warned on the negative impact of currency movements on the remainder part of the a Read More
LONDON (Alliance News) - Vectura PLC said Monday it has appointed Anne Whitaker as non-executive director of the drug development firm from the start of June.Whitaker served as president of Read More
LONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday said its Trelegy Ellipta treatment showed results better than two other treatments in tests over its efficacy for chronic obstructive the Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 6.0%. The drugmaker said it will acquire in Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------Next, Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said on Friday it has withdrawn from the process relating to buying Pfizer Inc's Consumer Healthcare we will continue to that Read More
LONDON (Alliance News) - FTSE 100-listed Reckitt Benckiser PLC on Thursday said it has ended talks with US firm Pfizer Inc over a takeover of the latter's Consumer Rakesh Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday its asthma and chronic obstructive pulmonary disease drug Relvar Ellipta has received a "positive" EU with Read More